Bionano Genomics, Inc. - Common Stock (BNGO)
2.9693
-0.0607 (-2.00%)
NASDAQ · Last Trade: Apr 7th, 11:05 AM EDT

QUEBEC CITY, Canada, Nov. 15, 2023 (GLOBE NEWSWIRE) -- LeddarTech®, an automotive software company that provides patented disruptive low-level sensor fusion and perception software technology for ADAS and AD, proudly announces the appointment of Mr. Chris Stewart as Chief Financial Officer (“CFO”).
By LeddarTech inc. · Via GlobeNewswire · November 15, 2023

Revenues are increasing, but with its meme stock heyday well in the rearview mirror, it's fair to ask whether Bionano Genomics stock is a risk worth taking
Via MarketBeat · March 13, 2023

With less than three weeks gone so far this year, we’re once again excited about NVIDIA’s stock, and aren’t the only ones.
Via MarketBeat · January 23, 2023
5 Biotech Stocks Under $5: Bionano Genomics, Northwest BioTherapeutics Plus 3 More Stocks
September 15, 2022 – TheNewswire - The biotechnology industry comprises hundreds of public companies that are fusing biology with technology to develop novel drugs and new products to advance the health of humanity.
Via TheNewswire.com · September 15, 2022
Global Market For Sleep Aid Devices Could Reach $112.7 Billion By 2025
Palm Beach, FL – April 23, 2021 – Sleep is an essential need of all species… including homo sapiens, especially now during the pandemic. Sleep disorders are affecting a large pool of population, which has boosted the awareness about these disorders and other related ailments. Increase in the prevalence of sleep disorders has led to an expansion of private care centers and hospitals. These sleep centers have increased awareness among people about the importance of tracking sleep patterns for better sleep. This is driving the usage of home sleep screening devices for sleep disorder cases, and subsequently increasing the revenue generation of the home sleep screening devices market. Various reports project that the market for sleep aides or technical devices should continue to grow for at least the next several years. One such report from Zion marketing (discussed in IPS News) said that the global demand for Sleep Tech Devices Market was valued at approximately USD 11.79 Billion in 2018, and is expected to generate revenue of around USD 26.62 Billion by end of 2025, growing at a CAGR of around 12.44 % between 2018 and 2025. Another report from BCC Research projected even higher revenues saying: “The global market for sleep aids should grow from $81.2 billion in 2020 to $112.7 billion by 2025 with a compound annual growth rate (CAGR) of 6.8% for the period of 2020-2025.” Active companies in the markets this week include Ocugen, Inc. (NASDAQ: OCGN), Hapbee Technologies, Inc. (OTCQB: HAPBF) (TSX-V: HAPB), Bionano Genomics, Inc. (NASDAQ: BNGO), Onconova Therapeutics, Inc. (NASDAQ: ONTX), Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP).
Via FinancialNewsMedia · April 23, 2021